Organon have announced an agreement with Eli Lilly and Company to become the sole distributor and promoter for the migraine medicines Emgality (galcanezumab) and RAYVOW (lasmiditan) in Europe.
Stanley Capital Partners announces its portfolio company, Laboratoire X.O, has completed the acquisition of the prescription drug Nimodipine under the brand name Nimotop from Bayer for several markets globally excluding mainland China.
Nataliya Andreychuk, the co-founder and CEO of Viseven, reveals her personal battle against breast cancer. Her story is a testament to enduring strength, tenacity, and sincere commitment to make a genuine difference in patients’ lives.
Sirio Pharma Co has announced the addition of new gummy manufacturing capabilities at its Best Formulations site, the company's manufacturing facility in the United States.
Helping to make pharmaceutical manufacturing compliant, safer, and faster, tech startup Leucine is today announcing a $7M series A funding round led by Ecolab Inc., a strategic investor, to scale its Compliance Cloud platform globally.
The first legal medical cannabis factory on the island of Ireland is on course to start production in 2024. Growth Industries Pharma Ltd has been able to push ahead with its construction of a facility to grow medical cannabis.
Justin Wilson, a partner and life sciences specialist at European intellectual property firm, Withers & Rogers explores why M&A are pushing to secure a slice of the gene therapy opportunity.
In our latest EPM Magazine Issue, Christiane Schuler, Communication Manager, at Siemens explores the role Siemens played in helping create one of the world's premier pharma production facilities.
Ypsomed has concluded a long-term supply agreement with Novo Nordisk for large quantities of autoinjectors. The autoinjectors will be used to administer drugs for the self-treatment in various metabolic indications.
